TP53 and cancer: CENPF exhibited high expression levels in the cancer tissues and related to metastasis, the frequency of somatic mutations in tumor suppressor genes (TP53, MSH2, RB1), as well as genes implicated in tumorigenesis pathways, cell cycle regulation, and DNA damage and repair mechanisms [6].